Ally Financial’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.01M | Sell |
25,000
-128,000
| -84% | -$14.8M | 0.37% | 58 |
|
|
2025
Q4 | $16.1M | Hold |
153,000
| – | – | 1.97% | 10 |
|
|
2025
Q3 | $12.8M | Buy |
153,000
+40,000
| +35% | +$3.29M | 1.59% | 9 |
|
|
2025
Q2 | $8.95M | Hold |
113,000
| – | – | 1.01% | 16 |
|
|
2025
Q1 | $10.1M | Buy |
113,000
+16,000
| +16% | +$1.49M | 1.14% | 19 |
|
|
2024
Q4 | $9.65M | Buy |
97,000
+32,000
| +49% | +$3.3M | 1.18% | 16 |
|
|
2024
Q3 | $7.38M | Buy |
65,000
+37,000
| +132% | +$4.4M | 0.89% | 23 |
|
|
2024
Q2 | $3.47M | Buy |
28,000
+8,000
| +40% | +$1.03M | 0.43% | 58 |
|
|
2024
Q1 | $2.64M | Sell |
20,000
-23,000
| -53% | -$2.83M | 0.36% | 67 |
|
|
2023
Q4 | $4.69M | Buy |
43,000
+10,000
| +30% | +$1.04M | 0.61% | 41 |
|
|
2023
Q3 | $3.4M | Buy |
+33,000
| New | +$3.56M | 0.5% | 53 |
|
|
2022
Q2 | – | Sell |
-250,000
| Closed | -$20.5M | – | 121 |
|
|
2022
Q1 | $20.5M | Buy |
250,000
+144,000
| +136% | +$11.4M | 2.36% | 14 |
|
|
2021
Q4 | $8.12M | Sell |
106,000
-94,000
| -47% | -$7.49M | 0.74% | 35 |
|
|
2021
Q3 | $15M | Hold |
200,000
| – | – | 1.47% | 16 |
|
|
2021
Q2 | $15.6M | Sell |
200,000
-9,600
| -5% | -$714K | 1.54% | 15 |
|
|
2021
Q1 | $15.4M | Buy |
209,600
+50,304
| +32% | +$3.71M | 1.47% | 18 |
|
|
2020
Q4 | $12.4M | Buy |
159,296
+62,880
| +65% | +$4.81M | 1.17% | 24 |
|
|
2020
Q3 | $7.63M | Hold |
96,416
| – | – | 1.23% | 23 |
|
|
2020
Q2 | $7.11M | Hold |
96,416
| – | – | 1.17% | 23 |
|
|
2020
Q1 | $7.08M | Buy |
96,416
+28,296
| +42% | +$2.22M | 0.76% | 18 |
|
|
2019
Q4 | $5.91M | Hold |
68,120
| – | – | 0.97% | 26 |
|
|
2019
Q3 | $5.47M | Hold |
68,120
| – | – | 0.97% | 29 |
|
|
2019
Q2 | $5.45M | Buy |
68,120
+36,680
| +117% | +$2.81M | 0.94% | 28 |
|
|
2019
Q1 | $2.5M | Buy |
+31,440
| New | +$2.35M | 0.48% | 68 |
|
|
2018
Q3 | – | Sell |
-186,544
| Closed | -$10.8M | – | 122 |
|
|
2018
Q2 | $10.8M | Hold |
186,544
| – | – | 2.12% | 6 |
|
|
2018
Q1 | $9.7M | Hold |
186,544
| – | – | 1.45% | 18 |
|
|
2017
Q4 | $10M | Buy |
186,544
+114,179
| +158% | +$6.33M | 1.93% | 13 |
|
|
2017
Q3 | $4.42M | Buy |
72,365
+19,965
| +38% | +$1.21M | 0.84% | 41 |
|
|
2017
Q2 | $3.21M | Hold |
52,400
| – | – | 0.64% | 58 |
|
|
2017
Q1 | $3.18M | Buy |
52,400
+31,440
| +150% | +$1.91M | 0.72% | 45 |
|
|
2016
Q4 | $1.18M | Buy |
+20,960
| New | +$1.23M | 0.2% | 92 |
|
|
2016
Q3 | – | Sell |
-199,120
| Closed | -$10.9M | – | 116 |
|
|
2016
Q2 | $10.9M | Sell |
199,120
-94,320
| -32% | -$5.02M | 1.83% | 11 |
|
|
2016
Q1 | $14.8M | Hold |
293,440
| – | – | 2.07% | 9 |
|
|
2015
Q4 | $14.8M | Hold |
293,440
| – | – | 2.06% | 9 |
|
|
2015
Q3 | $13.8M | Buy |
293,440
+20,960
| +8% | +$1.11M | 1.4% | 17 |
|
|
2015
Q2 | $14.8M | Hold |
272,480
| – | – | 1.5% | 15 |
|
|
2015
Q1 | $14.9M | Buy |
272,480
+36,680
| +16% | +$2.08M | 1.55% | 15 |
|
|
2014
Q4 | $12.8M | Buy |
235,800
+190,736
| +423% | +$10.6M | 1.41% | 13 |
|
|
2014
Q3 | $2.55M | Buy |
+45,064
| New | +$2.53M | 0.35% | 99 |
|
|
2014
Q2 | – | Sell |
-141,480
| Closed | -$7.66M | – | 141 |
|
|
2014
Q1 | $7.66M | Sell |
141,480
-209,600
| -60% | -$10.9M | 0.82% | 42 |
|
|
2013
Q4 | $16.8M | Hold |
351,080
| – | – | 1.78% | 12 |
|
|
2013
Q3 | $15.9M | Sell |
351,080
-141,270
| -29% | -$6.45M | 1.74% | 14 |
|
|
2013
Q2 | $21.8M | Buy |
+492,350
| New | +$22M | 2.15% | 3 |
|
Other funds holding MRK
VCM
VPM
Ally Financial's MRK Position: Q1 2026 in Review
Ally Financial reduced its Merck (MRK) stake by 84% in Q1 2026, selling an estimated $14.8M and leaving 25,000 shares worth $3.01M. The position accounts for 0.37% of the portfolio, ranked #58.
Ally Financial first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. The position peaked at $21.8M in Q2 2013. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Ally Financial held 25,000 shares of Merck worth $3.01M as of Q1 2026.
- Ally Financial sold 128,000 Merck shares in Q1 2026, an estimated $14.8M.
- Merck made up 0.37% of Ally Financial's portfolio in Q1 2026, its #58 holding.
- Ally Financial first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
- Ally Financial's Merck position peaked at $21.8M in Q2 2013.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Ally Financial's 13F filing for Q1 2026, filed 12 May 2026.